EXO EXOR N.V.

Clarivate and Exor sign agreement

Clarivate and Exor sign agreement

Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company’s Board of Directors

Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the Company’s Management and Board, and announces it now has a 10.1% shareholding in the Company and can increase its participation up to 17.5%

London, U.K., and Amsterdam, the Netherlands, March 4, 2024 – (NYSE: CLVT), a leading global provider of transformative intelligence and (AEX:EXO), the Netherlands-based diversified holding company, today announced that Suzanne Heywood will be nominated for election to the Clarivate Board of Directors at the Company’s next Annual General Meeting of shareholders on May 7, 2024. Under the terms of the agreement, Exor, which now owns 10.1% of Clarivate, may increase its participation up to 17.5% of Clarivate’s outstanding ordinary share capital.

Jonathan Gear, CEO, Clarivate said: “We welcome Exor’s commitment to our strategy as a long-term investor. I’m encouraged by their vote of confidence that conveys faith in our abilities to deliver solutions that our customers trust to fuel the world’s greatest breakthroughs.”

Andy Snyder, Chairman of the Board, Clarivate, commented: “We look forward to Suzanne joining the Board. She will bring tremendous in-depth experience from multiple Board roles for large global corporations and her guidance will be invaluable as we continue to transform Clarivate into a world-leading intelligence provider.”

Suzanne Heywood said, “We are delighted to be a shareholder of Clarivate, a global provider of data, analytics, technology and expert services to several sectors including healthcare. By bringing our experience of building great companies to the board level, we look forward to help Clarivate achieve ambitious goals and express its full potential.”

Suzanne Heywood is the COO of Exor and the Chair of CNH Industrial N.V. and Iveco Group. She was born in Southampton, England and has a Science MA from Oxford University and PhD from Cambridge University that she gained after a childhood spent sailing around the world on a boat. Suzanne started her professional career in the UK Treasury. In 1997, she joined McKinsey & Company where she held increasingly senior positions including, as a Senior Partner, co-leading McKinsey’s global service line on operating model change. Suzanne is also a Board member of The Economist and Louboutin.

# # #

About Clarivate

Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit .com

About Exor

Exor N.V. (AEX: EXO), is a diversified holding company that is based in the Netherlands and listed on the AEX. For over a century, Exor has built great companies and made successful investments worldwide, applying a culture that combines entrepreneurial spirit and financial discipline. Its portfolio is principally made up of companies in which Exor is the largest shareholder including Ferrari, Stellantis, CNH Industrial and Philips. For more information, please visit

Media contacts

-

Attachment



EN
04/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EXOR N.V.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: Serbia regulation to be litigated at international level. CM.com: Preview FY25. dsm-firmenich: At last! Exor: Stellantis shares fall sharply on €22bn turnaround plan, writeoff. Euronext: 2026 starting strong. Proximus: €275m impairment at Proximus Global

 PRESS RELEASE

Exor Press Release - 2026 Corporate Calendar

Exor Press Release - 2026 Corporate Calendar Amsterdam, 30 January 2026 EXOR PUBLISHES ITS 2026 CORPORATE CALENDAR Exor N.V. announced today the following corporate calendar for 2026: 23 March 2026: Publication of the financial statements for the full year 202524 March 2026: Investor & Analyst Call20 May 2026: Annual General Meeting of Shareholders22 September 2026: Publication of the interim financial statements for the half year 2026 The 2026 corporate calendar will be available on Exor’s website under the section. Any changes will be disclosed to the market on a timely basis. ...

 PRESS RELEASE

Exor-Ferrari Family Press Release - Shareholders' Agreement

Exor-Ferrari Family Press Release - Shareholders' Agreement Amsterdam, 3 January 2026 EXOR AND THE FERRARI FAMILY EXTEND SHAREHOLDERS’ AGREEMENT ON FERRARI Exor N.V., on the one hand, and Piero Ferrari and Trust Piero Ferrari, on the other hand, have agreed to renew the shareholders’ agreement relating to Ferrari N.V., confirming their respective alignment and commitment to Ferrari.         The new agreement enters into force upon expiration of the current shareholders’ agreement and will have a three-year term until 4 January 2029, with an automatic renewal for a further three-year perio...

Hilde Van Boxstael ... (+7)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Livio Luyten
  • Michiel Declercq
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

ResearchPool Subscriptions

Get the most out of your insights

Get in touch